Filing Flows › Relay Therapeutics (RLAY) › Q2 2026 › vs Q2 2025
Relay Therapeutics (RLAY) Q2 2026 vs Q2 2025 (year over year)
Relay Therapeutics's revenue fell $327K (-48%) from $677K in Q2 2025 to $350K in Q2 2026.
Relay Therapeutics, Q2 2026: revenue $350K (-48% year over year), net loss $83.7M, operating cash flow −$54.1M. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $350K | $677K | −$327K | -48% |
| Other income, net | $7.1M | $6.5M | $645K | +10% |
| Net loss | $83.7M | $70.4M | $13.3M | +19% |
| Costs & expenses | $91.2M | $77.5M | $13.7M | +18% |
| Operating costs | $91.2M | $77.5M | $13.7M | +18% |
| Research & development | $76.5M | $63.9M | $12.6M | +20% |
| General & admin | $14.7M | $13.6M | $1.1M | +8% |
| Operating cash sources | $83.7M | $70.4M | $13.3M | +19% |
| Depreciation | $360K | $1.0M | −$642K | -64% |
| Share-based compensation | $9.2M | $14.5M | −$5.3M | -37% |
| Working capital & other | $20.1M | −$388K | $20.4M | — |
| Cash used in operations | $54.1M | $55.3M | −$1.2M | -2% |
| Net loss absorbed | $83.7M | $70.4M | $13.3M | +19% |
Questions
How much did Relay Therapeutics's revenue grow year over year in Q2 2026?
Relay Therapeutics's revenue fell $327K (-48%) from $677K in Q2 2025 to $350K in Q2 2026.